Prediction of avatrombopag-induced thrombocytosis in pediatric immune thrombocytopenia: an AI-based real-world study

Abstract Avatrombopag (AVA), an oral thrombopoietin receptor agonist (TPO-RA), has demonstrated favorable efficacy in the treatment of pediatric immune thrombocytopenia (ITP). However, treatment-related thrombocytosis represents a clinically relevant adverse event that may compromise treatment safet...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xi Lin, Yuntian Wang, Yunqi Zhu, Nan Wang, Jingjing Liu, Zhifa Wang, Yu Hu, Shuyue Dong, Hui Chen, Jinxi Meng, Jingyao Ma, Zhenping Chen, Wensheng Zhang, Yongqiang Tang, Runhui Wu, Xiaoling Cheng
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Springer 2026-06-01
coleção:	Annals of Hematology
Assuntos:	Purpura Thrombocytopenic Idiopathic Avatrombopag Machine learning Thrombocytosis
Acesso em linha:	https://doi.org/10.1007/s00277-026-07086-x
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!